Deliver Your News to the World

News

Distribute Your News

  • Every day, hundreds of individuals and companies choose WebWire to distribute their news.
  • WebWire places your news within numerous highly trafficked news search engines generating leads and publicity.
  • Submit Your Release Now!

Health Care / Hospitals

Releases published in the last 30 days. RSS 0.91 Feed

Page 1 of 3

Blockchain in Healthcare Today Joins Coveted Scopus Index
Blockchain in Healthcare Today Joins Coveted Scopus Index
1/19/2022 8:30:00 AM
Blockchain in Healthcare Today (BHTY) is pleased to announce the open access peer reviewed journal has been accepted to the coveted Scopus index.   Owned by Elsevier Inc., Scopus is the largest abstract and citation database of peer-reviewed literature that is used by thousands of academic, government and corporate institutions; designed to serve the information needs of …
UK should prioritise vaccinating other countries over boosters at home – poll
UK should prioritise vaccinating other countries over boosters at home – poll
1/19/2022 4:16:31 AM
• 63% would prefer the UK to share vaccines with developing countries rather than deliver more boosters at home, to prevent the spread of new variant • 72% support the idea that ‘Ending the Covid-19 pandemic globally in 2022 should be the top priority for the UK Government • 72% believe the UK economy will continue to suffer until the pandemic is defeated globally …
Social Media Use and Physical Health
Social Media Use and Physical Health
1/18/2022 4:52:35 PM
Social media use was correlated with worse physical health indicators among college students, according to a new study published in the peer-reviewed journal Cyberpsychology, Behavior, and Social Networking.
BlueRock Therapeutics Announces First Patient Dosed in Canada in Phase 1 Trial in Patients with Advanced Parkinson’s Disease
BlueRock Therapeutics Announces First Patient Dosed in Canada in Phase 1 Trial in Patients with Advanced Parkinson’s Disease
1/18/2022 1:59:16 PM
BlueRock Therapeutics, a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, announced today the dose administration for the first patient in Canada in partnership with the University Health Network in a Phase 1 (Ph1), open-label trial of pluripotent stem cell-derived dopaminergic neurons in patients with advanced Parkinson’s disease.
HelpCare Plus Trends Among Affordable Telemedicine Services
HelpCare Plus Trends Among Affordable Telemedicine Services
1/17/2022 1:00:00 PM
Thanks to companies like HelpCare Plus, access to qualified health practitioners has become even more affordable and accessible to people from all over the world.
COVAX delivers its 1 billionth COVID-19 vaccine dose
COVAX delivers its 1 billionth COVID-19 vaccine dose
1/17/2022 11:12:40 AM
On 15 January 2022, a shipment of 1.1 million COVID-19 vaccines to Rwanda included the billionth dose supplied via COVAX. Together with our partners, COVAX is leading the largest vaccine procurement and supply operation in history, with deliveries to 144 countries to date.
MSF responds to latest WHO recommendation for COVID-19 medicine baricitinib
MSF responds to latest WHO recommendation for COVID-19 medicine baricitinib
1/17/2022 11:09:16 AM
As the World Health Organization (WHO) recommended baricitinib for the treatment of people with severe or critical  COVID-19, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) calls on governments to take immediate steps to ensure that patent monopolies do not stand in the way of access to this treatment.
Enhertu granted Priority Review in the US for patients with HER2-positive metastatic breast cancer treated with a prior anti-HER2-based regimen
Enhertu granted Priority Review in the US for patients with HER2-positive metastatic breast cancer treated with a prior anti-HER2-based regimen
1/17/2022 10:26:34 AM
AstraZeneca and Daiichi Sankyo have received notification of acceptance of the supplemental Biologics License Application (sBLA) of  Enhertu  (trastuzumab deruxtecan) for the treatment of adult patients in the US with unresectable or metastatic HER2-positive breast cancer who have received a prior anti-HER2-based regimen.
U.S. FDA Approves New MENTOR® MemoryGel BOOST™ Breast Implant
U.S. FDA Approves New MENTOR® MemoryGel BOOST™ Breast Implant
1/14/2022 10:48:16 AM
Mentor Worldwide LLC, the number one global brand in breast aesthetics, and part of the Johnson & Johnson Medical Devices Companies** announced that the U.S.
Leaders across healthcare, academia and technology form new coalition to transform healthcare journey through responsible AI adoption
Leaders across healthcare, academia and technology form new coalition to transform healthcare journey through responsible AI adoption
1/13/2022 12:00:38 PM
Leading public, private, educational and research organizations across the U.S. healthcare and life sciences industries announced the formation of the Artificial Intelligence Industry Innovation Coalition (AI3C).
NeuraLight Augments Leadership Team with Ex-Flatiron CTO, Gil Shklarski, as Scientific Co-Founder and Board Observer
1/13/2022 9:17:53 AM
NeuraLight, the company digitizing neurological insights with AI, today announced the addition of Gil Shklarski, Ph.D. as Scientific Co-Founder and Board Observer.
Novartis and Molecular Partners report positive topline data from Phase 2 study for ensovibep (MP0420), a DARPin antiviral therapeutic for COVID-19
Novartis and Molecular Partners report positive topline data from Phase 2 study for ensovibep (MP0420), a DARPin antiviral therapeutic for COVID-19
1/12/2022 5:06:06 PM
• Topline results from the randomized EMPATHY Part A study in acute COVID-19 ambulatory patients comparing single intravenous doses of ensovibep, a DARPin antiviral therapeutic candidate vs.
Henkel low pressure molding materials protect and seal medical electronics
Henkel low pressure molding materials protect and seal medical electronics
1/12/2022 4:09:16 PM
Henkel has introduced three new low pressure molding (LPM) materials designed to seal and protect medical devices from moisture, temperature extremes, chemicals, vibration, impact and other environmental concerns.
P&R Dental Strategies Announces Acquisition by The Beekman Group
1/12/2022 10:00:00 AM
P&R Dental Strategies, LLC (P&R), the premier dental insights company delivering customized, actionable business intelligence and claim review services to support a variety of dental industry stakeholders, today announced it has been acquired by an affiliate of The Beekman Group (Beekman) investing alongside the P&R management team.
Prosperity Through Equity Survey Launched By Thomas P. Miller & Associates (TPMA) Reveals Massive Disparities In Accessing Mental and Physical Healthcare Support Amid COVID-19 Recovery
1/12/2022 8:00:00 AM
Thomas P. Miller and Associates (’TPMA’), a national workforce and economic development consulting firm, in launching its ’Prosperity Through Equity Survey’, an American stakeholder engagement initiative aimed at garnering actionable intelligence and insight from across 50 States, has derived that nearly seven in ten (69%) polled suggest that lack of access to quality …
Sabre SafePoint adds travel restriction tracking capability
Sabre SafePoint adds travel restriction tracking capability
1/11/2022 8:18:21 PM
Sabre Corporation   (NASDAQ: SABR), the leading software and technology provider that powers the global travel industry, announces the expansion of SafePoint, a travel risk management product, to include global travel restriction tracking.
Creating the mental health workforce of the future
Creating the mental health workforce of the future
1/11/2022 12:58:23 PM
There is an urgent need to provide universal access to effective, equitable mental health and addiction care services in this country. The mental health care access challenges facing health care organizations are layered and complex, and at Kaiser Permanente we believe it’s time to prioritize expanding the available mental health workforce as a part of the solution.
Sight Diagnostics® and Inter Medico Announce the Health Canada Approval of Sight OLO for Point-of-Care Testing
Sight Diagnostics® and Inter Medico Announce the Health Canada Approval of Sight OLO for Point-of-Care Testing
1/10/2022 2:42:13 PM
Tel Aviv, Israel (January 10, 2022) - Sight Diagnostics, the company delivering lab-grade Complete Blood Count (CBC) results in minutes, today announced it has received Health Canada approval to provide Sight OLO® analyzers for point-of-care settings.
“Reclaim Your Hero” is Now Free on Amazon for 5 Days (until 01/14/2022)
“Reclaim Your Hero” is Now Free on Amazon for 5 Days (until 01/14/2022)
1/10/2022 1:24:46 PM
Best Seller Publishing announces the release of Mathew Grace’s new book, “Reclaim Your Hero: Transform Your Pain into Power and thrive. Numquam Deficio (Never Quit).” It will be available for free download in the Amazon Kindle Store until January 14th.
Novel Brainstem Circuit Gives Rise to the Rhythms of Vocalization
Novel Brainstem Circuit Gives Rise to the Rhythms of Vocalization
1/10/2022 8:10:05 AM
The vocal sounds of humans - laughing, crying, and the babbling of babies - have the same rhythmic quality as the sounds made by many mammals, songbirds, and even some species of fish.